• Return to Headlines

Shares of Biotelemetry Inc Has Risen Above Previous 52-Week High

By David Diaz

Biotelemetry Inc (NASDAQ:BEAT) traded at a new 52-week high today of $34.90. So far today approximately 157,000 shares have been exchanged, as compared to an average 30-day volume of 192,000 shares.

Biotelemetry Inc has overhead space with shares priced $34.60, or 8.9% below the average consensus analyst price target of $38.00. The stock should discover initial support at its 50-day moving average (MA) of $12.44 and subsequent support at its 200-day MA of $12.39.

BioTelemetry, Inc. provides ambulatory outpatient management solutions for monitoring clinical information regarding an individual's health. The Company's initial efforts are focused on the diagnosis and monitoring of cardiac arrhythmias, and heart rhythm disorders.

In the past 52 weeks, Biotelemetry Inc share prices have been bracketed by a low of $14.72 and a high of $34.90 and are now at $34.60, 135% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.7% while the 50-day MA has advanced 2.4%.

SmarTrend recommended that subscribers consider buying shares of Biotelemetry Inc on June 28th, 2017 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $32.05. Since that recommendation, shares of Biotelemetry Inc have risen 7.3%. We continue to monitor BEAT for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows biotelemetry inc

Ticker(s): BEAT